CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,586,000 | $8,368,000 | $4,327,000 | $7,989,000 |
| Dep. & Amort. | $4,597,000 | $4,366,000 | $4,224,000 | $4,486,000 |
| Deferred Tax | -$572,000 | -$676,000 | -$2,029,000 | -$402,000 |
| Stock-Based Comp. | $540,000 | $588,000 | $447,000 | $484,000 |
| Change in WC | $109,000 | $15,000 | $6,818,000 | $3,857,000 |
| Other Non-Cash | -$153,000 | $765,000 | $2,390,000 | $1,851,000 |
| Operating Cash Flow | $9,107,000 | $13,426,000 | $16,177,000 | $18,265,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,781,000 | -$3,031,000 | -$2,727,000 | -$2,520,000 |
| Net Acquisitions | -$95,000 | -$16,612,000 | -$1,388,000 | -$146,000 |
| Inv. Purchases | -$15,191,000 | -$9,043,000 | -$7,746,000 | -$9,963,000 |
| Inv. Sales/Matur. | $10,353,000 | $7,729,000 | $6,729,000 | $7,246,000 |
| Other Inv. Act. | $101,000 | $68,000 | $85,000 | $122,000 |
| Investing Cash Flow | -$7,613,000 | -$20,889,000 | -$5,047,000 | -$5,261,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5,059,000 | $7,932,000 | -$4,211,000 | -$9,267,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$3,023,000 | -$2,012,000 | -$3,500,000 | $0 |
| Dividends Paid | -$3,373,000 | -$3,132,000 | -$2,907,000 | -$2,625,000 |
| Other Fin. Act. | $202,000 | -$105,000 | $102,000 | $536,000 |
| Financing Cash Flow | -$1,135,000 | $2,683,000 | -$10,516,000 | -$11,356,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $359,000 | -$4,780,000 | $614,000 | $1,648,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,525,000 | $13,305,000 | $12,691,000 | $11,043,000 |
| End Cash | $8,884,000 | $8,525,000 | $13,305,000 | $12,691,000 |
| Free Cash Flow | $6,326,000 | $10,395,000 | $13,450,000 | $15,745,000 |